<unk>  is an interleukin-1 receptor antagonist that is FDA approved for the {{{indicationType}}} of rheumatoid arthritis (RA)and cryopyrin-associated periodic syndromes (CAPS).   Common adverse reactions include upper respiratory tract infection, headache, nausea, diarrhea, sinusitis, arthralgia, flu like-symptoms, and abdominal pain.
Anakinra
Canakinumab
Nebacumab
Sarilumab
Glatiramer
Crofelemer
Tofacitinib
Ecallantide